Day: November 17, 2025

WASHINGTON, Nov. 17, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) (“ASP Isotopes” or the “Company”), an advanced materials company focused on developing technologies and processes for the production of isotopes for multiple industries, today announced it will hold a quarterly business update conference call and webcast on Friday, November 21, 2025 at 8:30 a.m. (Eastern Time). Conference Call Information To participate in this event, please log on or dial in approximately 5 minutes before the beginning of the call. Webcast Link https://events.q4inc.com/attendee/428149635 Participant Dial-In Details Date: November 21, 2025Time: 8:30 a.m. ESTDial in:USA / International Toll: +1 .646.968.2525 USA – Toll-Free: +1.888.596.4144 Canada – Toronto: +1.647.495.7514 Canada – Toll-Free: +1.888.596.4144Conference...

WAYNE, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases, today announced the grant of inducement equity awards to three new employees. The Compensation Committee of the Board of Directors of Avalo approved the grants of nonstatutory stock options to purchase an aggregate of 114,000 shares of common stock (the “Options”) as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The Options were granted on November 4, November 10, and November 17, 2025, and entitle the recipients to purchase 24,000 shares of common stock, 72,000 shares of common stock, and 18,000 shares of common stock, respectively,...

Paris, France – November 17, 2025 – Eviden, the Atos Group product brand leading in advanced computing, announces today the rankings of its 58 Eviden-built systems1 in the TOP500 and Green500, official listings of the world’s most powerful and most energy-efficient supercomputers. Amongst the 58 Eviden-built systems listed in the TOP500, JUPITER, through its Booster partition, remains the 4th most powerful supercomputer in the world and Europe’s 1st, marking a historic milestone as Europe’s first system to officially break the symbolic ExaFlop barrier – one billion billion calculations per second. Eviden also leads the Green500 for the fourth edition in a row, claiming the top three spots with its Eviden-built systems KAIROS (CALMIP), ROMEO (URCA), and the Levante GPU extension (DKRZ) – and with JUPITER being recognized as the most energy-efficient...

MONTREAL, Nov. 17, 2025 (GLOBE NEWSWIRE) — MTY Food Group Inc. (“MTY”, “MTY Group” or the “Company”) (TSX: MTY), one of the largest franchisors and operators of multiple restaurant concepts worldwide, is responding to certain statements in the media. Following a recent press article, MTY Group confirms that the Board of Directors of the Company has initiated a strategic review process and engaged a financial advisor to identify, review and evaluate potential strategic alternatives with a view toward continuing to enhance shareholder value. The Company is exploring a range of such alternatives including, but not limited to, a sale of all or part of the company as well as continuing to execute its current business plan. There can be no assurance that any transaction will occur, and the Company...

WALTHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 451,448 shares of the Company’s ordinary shares to eight non-executive employees as equity inducement awards under the Crescent Biopharma, Inc. 2025 Employment Inducement Incentive Award Plan, as amended (the “Inducement Plan”). The options were approved on November 14, 2025 and were material to each employee’s acceptance of employment with Crescent, in accordance with Nasdaq Listing Rule 5635(c)(4). The options were granted with a 10-year term and an exercise price...

CHANDLER, Ariz., Nov. 17, 2025 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Wells Fargo 9th Annual TMT Summit on Tuesday, November 18, 2025 at 12:45 p.m. (Pacific Time). Presenting for the Company will be Mr. Eric Bjornhoolt, Senior Vice President and Chief Financial Officers, and Mr. Sajid Daudi, Head of Investor Relations. A live webcast of the presentation will be made available by Wells Fargo, and can be accessed on the Microchip website at www.microchip.com. Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies of SEC filings...

RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced the closing of its underwritten registered public offering of 5,366,667 common shares (which amount includes exercise in full of the underwriters’ option to purchase additional common shares) at a public offering price of $7.50 per share. Fennec’s total gross proceeds from the offering (before deducting the underwriting discounts and offering expenses) are approximately $40,250,000. Fennec intends to use the net proceeds of the offering to repurchase and redeem certain indebtedness and the remaining net proceeds for working capital and general corporate purposes. Piper Sandler & Co. and Craig-Hallum Capital Group LLC acted as the...